Authors' response to Tran et al.'s comment on “The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications”

Yitayeh Belsti, Aya Mousa, Hannah Jackson, Lisa J. Moran, Kirsten R. Palmer, Raja Ram Dhungana, Emily Callander, Daniel Lorber Rolnik, Helena Teede, Joanne Enticott

Research output: Contribution to journalLetterpeer-review

Abstract

Dear Editor,

We appreciate the time and effort that Tran and colleagues [1] have taken to review our recent study, titled "The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications", published in Drug Safety [2]. We are grateful for the constructive feedback and the interest in conducting further analyses. We would like to begin by clarifying that most issues raised are already addressed in the article, with the exception of expanded obstetric complication regressions (paragraph 5 below and Table 1) and covariate overlap (paragraph 6 below and Table 2 below).
Original languageEnglish
Pages (from-to)439-441
Number of pages3
JournalDrug Safety
Volume48
Issue number4
DOIs
Publication statusPublished - Apr 2025
Externally publishedYes

Keywords

  • Combination drug therapy
  • Drug Regulation
  • Drugs
  • Medical Sociology
  • Gestational diabetes
  • Maternal and Child Health

Fingerprint

Dive into the research topics of 'Authors' response to Tran et al.'s comment on “The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications”'. Together they form a unique fingerprint.

Cite this